"Electrifying dysmorphology": Potassium channelopathies causing dysmorphic syndromes.
Abnormalities, Multiple
/ drug therapy
Andersen Syndrome
/ drug therapy
Cardiomegaly
/ drug therapy
Channelopathies
/ drug therapy
Child
Craniofacial Abnormalities
/ drug therapy
Fibromatosis, Gingival
/ drug therapy
Hallux
/ abnormalities
Hand Deformities, Congenital
/ drug therapy
Humans
Hypertrichosis
/ drug therapy
Intellectual Disability
/ drug therapy
Muscle Hypotonia
/ drug therapy
Nails, Malformed
/ drug therapy
Osteochondrodysplasias
/ drug therapy
Potassium Channels
/ genetics
Thumb
/ abnormalities
Channelopathies
Dysmorphology
Potassium channels
Rare diseases
Translational medicine
Journal
Advances in genetics
ISSN: 0065-2660
Titre abrégé: Adv Genet
Pays: United States
ID NLM: 0370421
Informations de publication
Date de publication:
2020
2020
Historique:
entrez:
21
6
2020
pubmed:
21
6
2020
medline:
13
1
2021
Statut:
ppublish
Résumé
Potassium channels are a heterogeneous group of membrane-bound proteins, whose functions support a diverse range of biological processes. Genetic disorders arising from mutations in potassium channels are classically recognized by symptoms arising from acute channel dysfunction, such as periodic paralysis, ataxia, seizures, or cardiac conduction abnormalities, often in a patient with otherwise normal examination findings. In this chapter, we review a distinct subgroup of rare potassium channelopathies whose presentations are instead suggestive of a developmental disorder, with features including intellectual disability, craniofacial dysmorphism or other physical anomalies. Known conditions within this subgroup are: Andersen-Tawil syndrome, Birk-Barel syndrome, Cantú syndrome, Keppen-Lubinsky syndrome, Temple-Baraitser syndrome, Zimmerman-Laband syndrome and a very similar disorder called Bauer-Tartaglia or FHEIG syndrome. Ion channelopathies are unlikely to be routinely considered in the differential diagnosis of children presenting with developmental concerns, and so detailed description and photographs of the clinical phenotype are provided to aid recognition. For several of these disorders, functional characterization of the genetic mutations responsible has led to identification of candidate therapies, including drugs already commonly used for other indications, which adds further impetus to their prompt recognition. Together, these cases illustrate the potential for mechanistic insights gained from genetic diagnosis to drive translational work toward targeted, disease-modifying therapies for rare disorders.
Identifiants
pubmed: 32560786
pii: S0065-2660(20)30005-5
doi: 10.1016/bs.adgen.2020.03.002
pii:
doi:
Substances chimiques
Potassium Channels
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
137-174Informations de copyright
© 2020 Elsevier Inc. All rights reserved.